| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327529 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
The high incidence of ovarian cancer suggests that oophorectomy should be recommended in female BRCA1 and BRCA2 mutation carriers with a diagnosis of breast cancer, especially those with stage I disease. Breast cancer systemic therapy did not significantly alter the risk of ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Kelly A. Metcalfe, Henry T. Lynch, Parviz Ghadirian, Nadine Tung, Ivo A. Olivotto, William D. Foulkes, Ellen Warner, Olufunmilayo Olopade, Andrea Eisen, Barbara Weber, Jane McLennan, Ping Sun, Steven A. Narod,